VISCODERM referencias disponibles en ALLPARA para uso profesional, de origen directo y certificadas en cada envío.
Viscoderm Skinkò
Viscoderm Skinkò is an injectable medical device, designed for deep revitalisation of the superficial and middle dermis. It is suitable for qualified practitioners treating the face and neck of healthy adult patients presenting early signs of ageing, superficial fine lines and dehydrated skin. The product combines non-reticulated hyaluronic acid of biotechnological origin with a buffered medium containing over 50 essential nutrients and is intended for professional use.
Principales ventajas de Viscoderm Skinkò
- CE-marked Class III injectable medical device, CE 0123
- Non-reticulated hyaluronic acid of biotechnological origin, for high biocompatibility
- Buffered medium supplying over 50 essential nutrients, including vitamins, minerals and amino acids
- Improves the moisture levels of the facial epidermis
- Reduces the appearance of early-stage fine lines
- Normalises the skin's physiological environment and provides an antioxidant effect
- Restores the skin's natural glow and hydrodynamic balance
Indicaciones y uso profesional
Indicaciones principales
- Early signs of ageing and superficial fine lines
- Dehydrated facial epidermis
- Loss of skin radiance and vitality
- Skin requiring deep revitalisation of the superficial and middle dermis
Uso profesional
Viscoderm Skinkò is a Class III injectable medical device supplied for professional use only and is intended to be injected by a doctor experienced in the anatomy and physiology of the site to be treated. It is placed in the superficial or middle dermis of the face, with a 30G needle per injection area and separate needles for drawing up and injecting. Injection technique at the practitioner's discretion, following the manufacturer's current instructions. The protocol is three injection sessions at a maximum of every three weeks, not exceeding one 5 ml vial per session; touch-up sessions are needed to maintain the result. Apply only to healthy skin, and do not inject into the eyelids, glabella, eye circles or lips, nor into tendons, ligaments, bones, muscles or blood vessels.
Perfil del paciente
Viscoderm Skinkò is intended for healthy adult patients presenting early signs of ageing, superficial fine lines, a dehydrated facial epidermis or loss of skin radiance and vitality, and is indicated for the superficial and middle dermis of the face, including the peri-orbital, peribuccal, nasolabial folds and marionette lines. Suitability in any individual case is determined by the treating practitioner following clinical assessment. It must not be used in patients with known hypersensitivity or allergy to any of the components, in patients with a skin disease or skin alteration of any type, in patients with a history of auto-immune disease or receiving immunotherapy, in pregnant or breastfeeding women, or in people under 18 years of age. Patients with a history of streptococcal disease, such as recurrent angina or acute articular rheumatism, must undergo a double test before any injection, and injection is not recommended in acute articular rheumatism with cardiac involvement.
Cómo funciona Viscoderm Skinkò
Viscoderm Skinkò works through non-reticulated hyaluronic acid of biotechnological origin, delivered in a buffered medium that carries over 50 essential nutrients including vitamins, minerals and amino acids. Injected into the superficial and middle dermis, the hyaluronic acid restores hydrodynamic balance while the nutrient complex normalises the skin's physiological environment and provides an antioxidant effect. This makes it suitable for early ageing and superficial fine lines, where the treatment goal is revitalisation and radiance rather than volume.
Por qué comprar en Allpara
Allpara ofrece productos VISCODERM originales y verificados de proveedores seleccionados, con trazabilidad completa de lotes y asesoramiento experto. Atendemos a clínicas y profesionales de la estética con productos con certificado CE, entrega rápida en toda la UE desde nuestro almacén en la UE y precios profesionales competitivos. Nuestra prioridad es la seguridad, la satisfacción y los resultados de sus pacientes, con un servicio posventa dedicado para su tranquilidad.
Preguntas frecuentes
How does Viscoderm Skinkò differ from Viscoderm Skinkò E?
Viscoderm Skinkò contains 2 mg of hyaluronic acid with the anti-ageing complex and targets early signs of ageing, superficial fine lines and dehydration. Viscoderm Skinkò E is the enriched version with 32 mg of hyaluronic acid, formulated for established wrinkles and loss of skin density.
Which nutrients does Viscoderm Skinkò supply?
Viscoderm Skinkò is supplied in a buffered medium containing over 50 essential nutrients, including vitamins, minerals and amino acids, alongside the hyaluronic acid.
Is the hyaluronic acid in Viscoderm Skinkò cross-linked?
No. Viscoderm Skinkò uses non-reticulated, that is non-cross-linked, hyaluronic acid of biotechnological origin.
Más productos de IBSA
ALIAXIN referencias disponibles en ALLPARA para uso profesional, de origen directo y certificadas en cada envío.
ALIAXIN Productos
Ver todo 6PROFHILO referencias disponibles en ALLPARA para uso profesional, de origen directo y certificadas en cada envío.
PROFHILO Productos
Ver todo 8SINOVIAL referencias disponibles en ALLPARA para uso profesional, de origen directo y certificadas en cada envío.
SINOVIAL Productos
Ver todo 4Alternativas para la clínica
Retome donde lo dejó
Viscoderm Skinkò
Viscoderm Skinkò is an injectable medical device, designed for deep revitalisation of the superficial and middle dermis. It is suitable for qualified practitioners treating the face and neck of healthy adult patients presenting early signs of ageing, superficial fine lines and dehydrated skin. The product combines non-reticulated hyaluronic acid of biotechnological origin with a buffered medium containing over 50 essential nutrients and is intended for professional use.
Principales ventajas de Viscoderm Skinkò
- CE-marked Class III injectable medical device, CE 0123
- Non-reticulated hyaluronic acid of biotechnological origin, for high biocompatibility
- Buffered medium supplying over 50 essential nutrients, including vitamins, minerals and amino acids
- Improves the moisture levels of the facial epidermis
- Reduces the appearance of early-stage fine lines
- Normalises the skin's physiological environment and provides an antioxidant effect
- Restores the skin's natural glow and hydrodynamic balance
Indicaciones y uso profesional
Indicaciones principales
- Early signs of ageing and superficial fine lines
- Dehydrated facial epidermis
- Loss of skin radiance and vitality
- Skin requiring deep revitalisation of the superficial and middle dermis
Uso profesional
Viscoderm Skinkò is a Class III injectable medical device supplied for professional use only and is intended to be injected by a doctor experienced in the anatomy and physiology of the site to be treated. It is placed in the superficial or middle dermis of the face, with a 30G needle per injection area and separate needles for drawing up and injecting. Injection technique at the practitioner's discretion, following the manufacturer's current instructions. The protocol is three injection sessions at a maximum of every three weeks, not exceeding one 5 ml vial per session; touch-up sessions are needed to maintain the result. Apply only to healthy skin, and do not inject into the eyelids, glabella, eye circles or lips, nor into tendons, ligaments, bones, muscles or blood vessels.
Perfil del paciente
Viscoderm Skinkò is intended for healthy adult patients presenting early signs of ageing, superficial fine lines, a dehydrated facial epidermis or loss of skin radiance and vitality, and is indicated for the superficial and middle dermis of the face, including the peri-orbital, peribuccal, nasolabial folds and marionette lines. Suitability in any individual case is determined by the treating practitioner following clinical assessment. It must not be used in patients with known hypersensitivity or allergy to any of the components, in patients with a skin disease or skin alteration of any type, in patients with a history of auto-immune disease or receiving immunotherapy, in pregnant or breastfeeding women, or in people under 18 years of age. Patients with a history of streptococcal disease, such as recurrent angina or acute articular rheumatism, must undergo a double test before any injection, and injection is not recommended in acute articular rheumatism with cardiac involvement.
Cómo funciona Viscoderm Skinkò
Viscoderm Skinkò works through non-reticulated hyaluronic acid of biotechnological origin, delivered in a buffered medium that carries over 50 essential nutrients including vitamins, minerals and amino acids. Injected into the superficial and middle dermis, the hyaluronic acid restores hydrodynamic balance while the nutrient complex normalises the skin's physiological environment and provides an antioxidant effect. This makes it suitable for early ageing and superficial fine lines, where the treatment goal is revitalisation and radiance rather than volume.
Por qué comprar en Allpara
Allpara ofrece productos VISCODERM originales y verificados, con trazabilidad completa de lotes, stock con certificado CE, entrega rápida en toda la UE y servicio posventa experto.
Preguntas frecuentes
How does Viscoderm Skinkò differ from Viscoderm Skinkò E?
Viscoderm Skinkò contains 2 mg of hyaluronic acid with the anti-ageing complex and targets early signs of ageing, superficial fine lines and dehydration. Viscoderm Skinkò E is the enriched version with 32 mg of hyaluronic acid, formulated for established wrinkles and loss of skin density.
Which nutrients does Viscoderm Skinkò supply?
Viscoderm Skinkò is supplied in a buffered medium containing over 50 essential nutrients, including vitamins, minerals and amino acids, alongside the hyaluronic acid.
Is the hyaluronic acid in Viscoderm Skinkò cross-linked?
No. Viscoderm Skinkò uses non-reticulated, that is non-cross-linked, hyaluronic acid of biotechnological origin.